Skip to main content
Journal ArticleOPEN ACCESS

Pricing cancer drugs: When does pricing become profiteering?

AMA Journal of Ethics (2015) 17(8) 750-753
DOI: 10.1001/journalofethics.2015.17.8.nlit1-1508
6Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Kushnick, H. L. (2015). Pricing cancer drugs: When does pricing become profiteering? AMA Journal of Ethics, 17(8), 750–753. https://doi.org/10.1001/journalofethics.2015.17.8.nlit1-1508

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free